Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd (SGRL) last traded at ₹510, a market capitalisation of ₹655 crore, on a P/E of 42.4. Over the past 52 weeks the stock has ranged between ₹381 and ₹759. Shree Ganesh Remedies Ltd last reported results for the quarter ended Jun 2026, with sales of ₹14.36 crore and net profit of ₹1.12 crore. Shree Ganesh Remedies Ltd’s annual general meeting is scheduled for 12 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.
Shree Ganesh Remedies Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Shree Ganesh Remedies Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹14.36 cr, down 41.8% from ₹24.67 cr a year earlier. Net profit was ₹1.12 cr, down 67.5% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 32.33 | 27.05 | 24.43 | 24.67 | 30.32 | 21.11 | 33.2 | 14.36 |
| Expenses | 21.02 | 17.14 | 14.55 | 17.37 | 20.7 | 14.38 | 21.82 | 11.01 |
| Operating profit | 11.31 | 9.91 | 9.88 | 7.3 | 9.62 | 6.73 | 11.38 | 3.35 |
| OPM % | 34.98% | 36.64% | 40.44% | 29.59% | 31.73% | 31.88% | 34.28% | 23.33% |
| Other income | 0.19 | 0.71 | 2.29 | 0.66 | 0.69 | 0.66 | 1.02 | 0.94 |
| Interest | 0.44 | 0.39 | 0.97 | 0.94 | 1.01 | 0.74 | 0.88 | 0.32 |
| Depreciation | 2.42 | 2.7 | 2.42 | 2.42 | 2.59 | 2.67 | 2.8 | 2.44 |
| Profit before tax | 8.64 | 7.53 | 8.78 | 4.6 | 6.71 | 3.98 | 8.72 | 1.53 |
| Tax % | 25.81% | 27.89% | 24.83% | 25.00% | 26.23% | 22.36% | 28.21% | 27.45% |
| Net profit | 6.41 | 5.42 | 6.59 | 3.45 | 4.96 | 3.09 | 6.27 | 1.12 |
| EPS (₹) | 4.99 | 4.22 | 5.13 | 2.69 | 3.86 | 2.41 | 4.88 | 0.87 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Shree Ganesh Remedies Ltd annual results
| ₹ crore | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 35 | 64 | 49 | 126 | 109 | 109 | 99 |
| Operating profit | 9 | 13 | 14 | 42 | 39 | 35 | 31 |
| OPM % | 25% | 20% | 28% | 33% | 36% | 32% | 31% |
| Net profit | 6 | 10 | 10 | 28 | 23 | 18 | 15 |
| EPS (₹) | 4.88 | 8.18 | 7.62 | 21.96 | 17.97 | 13.83 | 12.02 |
TTM is the trailing twelve months to the most recent quarter.
Shree Ganesh Remedies Ltd growth and returns
- 10 Years
- %
- 5 Years
- 17%
- 3 Years
- %
- TTM
- -9%
- 10 Years
- %
- 5 Years
- 11%
- 3 Years
- %
- TTM
- -29%
- 10 Years
- %
- 5 Years
- 12%
- 3 Years
- 7%
- 1 Year
- -12%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- 16%
- Last Year
- 11%
Shree Ganesh Remedies Ltd shareholding pattern
Promoters held 72.83% at Jun 2026, broadly unchanged since Jun 2025. FIIs 0.00% and DIIs 0.52%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 70.49% | 72.80% | 72.80% | 72.80% | 72.80% | 72.80% | 72.83% | 72.83% |
| FIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.52% |
| Public | 29.50% | 27.19% | 27.20% | 27.20% | 27.19% | 27.20% | 27.16% | 26.65% |
| No. of shareholders | 8,508 | 8,695 | 8,978 | 9,166 | 8,752 | 8,442 | 8,058 | 7,822 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
When is Shree Ganesh Remedies Ltd’s AGM?
Shree Ganesh Remedies Ltd’s annual general meeting is scheduled for 12 Sept 2026.
- AGM31st Annual General Meeting
See the full results calendar for every Indian company reporting in the next 30 days.
Shree Ganesh Remedies Ltd corporate filings
- Newspaper Publication for Notice of Annual General MeetingCompany Updatelow impact
Cruxal's analysis: Shree Ganesh Remedies Ltd has completed the mandatory newspaper publication for its…
Read the full analysis - Annual Report FY 2025-26Otherslow impact
Cruxal's analysis: Shree Ganesh Remedies Ltd has filed its Annual Report for the financial year 2025-26…
Read the full analysis - Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Shree Ganesh Remedies Ltd has fulfilled its regulatory obligation under Regulation 30 of…
Read the full analysis - Investor PresentationCompany Updatehigh impact
Cruxal's analysis: Shree Ganesh Remedies Limited reported a challenging Q1FY27, with revenue from operations…
Read the full analysis - Press ReleaseCompany Updatelow impact
Cruxal's analysis: Shree Ganesh Remedies Ltd has submitted a press release under Regulation 30 of the SEBI…
Read the full analysis - Outcome of Board MeetingBoard Meetinghigh impact
Cruxal's analysis: Shree Ganesh Remedies Limited reported a sharp contraction in its Q1 FY2027 financial…
Read the full analysis - Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve the Unaudited (Standalone ....Board Meetinglow impact
Cruxal's analysis: Shree Ganesh Remedies Limited has issued a formal notice under Regulation 29 of SEBI…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Shree Ganesh Remedies Ltd
Cruxal reads every Shree Ganesh Remedies Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.